Literature DB >> 7758477

Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

C Hennequin1, B Page, P Roux, C Legendre, H Kreis.   

Abstract

The charts for seven renal transplant recipients who developed Pneumocystis carinii pneumonia were reviewed. They included six men and one woman transplanted a mean of 150 days before the diagnosis of this infection. Six presented at least one episode of acute graft rejection. Cytomegalovirus pneumonia was diagnosed in six of the patients. All patients were treated with cotrimoxazole. Global mortality was 43%. In additional to the classic hypothesis of latent Pneumocystis carinii reactivation in immunocompromised hosts, this and previous reports of outbreaks strongly suggest either a person-to-person transmission or acquisition from the environment. Molecular typing of isolates could be of value in identifying the source of such outbreaks. Chemoprophylaxis should be more systematically administered to renal transplant patients, co-trimoxazole being the drug of choice.

Entities:  

Mesh:

Year:  1995        PMID: 7758477     DOI: 10.1007/BF02111870

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  [Pneumocystis carinii pneumonia in a kidney transplantation center in the proximity of an AIDS care unit].

Authors:  D Glotz; M Kazatchkine; F Vincent; H Haddad; A Duboust; P Druet; J Bariety
Journal:  Presse Med       Date:  1992 Dec 19-26       Impact factor: 1.228

3.  Pneumocystis carinii--new clinical spectrum?

Authors:  P D Walzer
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

4.  A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses.

Authors:  J L Jacobs; D M Libby; R A Winters; D M Gelmont; E D Fried; B J Hartman; J Laurence
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

5.  Pneumocystis carinii pneumonia: a cluster of eleven cases.

Authors:  C Singer; D Armstrong; P P Rosen; D Schottenfeld
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

6.  Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem.

Authors:  P K Peterson; R Ferguson; D S Fryd; H H Balfour; J Rynasiewicz; R L Simmons
Journal:  Medicine (Baltimore)       Date:  1982-11       Impact factor: 1.889

7.  Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections.

Authors:  P R Millard; A R Heryet
Journal:  J Pathol       Date:  1988-04       Impact factor: 7.996

8.  Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.

Authors:  A M Hardy; C P Wajszczuk; A F Suffredini; T R Hakala; M Ho
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

9.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

10.  Detection of Pneumocystis carinii with DNA amplification.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

View more
  15 in total

1.  Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA.

Authors:  N Maher; H K Dillon; S H Vermund; T R Unnasch
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

Review 2.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease.

Authors:  J van der Lelie; D Venema; E J Kuijper; R P van Steenwijk; M H van Oers; L L Thomas; A E von dem Borne
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

4.  In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Authors:  A Dhondt; R Vanholder; M A Waterloos; G Glorieux; R De Smet; S Ringoir
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

5.  Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution.

Authors:  C Demanche; M Berthelemy; T Petit; B Polack; A E Wakefield; E Dei-Cas; J Guillot
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Development and evaluation of a molecular viability assay for Pneumocystis carinii.

Authors:  N Maher; S Vermund; M Lasbury; C Lee; M Bartlett; T R Unnasch
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 7.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments.

Authors:  M Olsson; C Lidman; S Latouche; A Björkman; P Roux; E Linder; M Wahlgren
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation.

Authors:  Sabine Schmoldt; Regina Schuhegger; Thorsten Wendler; Ingrid Huber; Heidelore Söllner; Michael Hogardt; Helmut Arbogast; Jürgen Heesemann; Lutz Bader; Andreas Sing
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.